Alkylating agents - PDFSEARCH.IO - Document Search Engine

Alkylating agents
Results: 211

#	Item
61	improvement in survival compared to chlorambucil, it offers patients another choice in first-line treatment for CLL, and has a manageable toxicity profile. pERC deliberated on the potential cost-effectiveness of obinut Add to Reading List Source URL: www.pcodr.ca Language: English - Date: 2015-01-09 16:20:37 Alkylating antineoplastic agents Nitrogen mustards Organochlorides Medical statistics Lymphocytic leukemia B-cell chronic lymphocytic leukemia Leukemia Fludarabine Chlorambucil Chemistry Medicine Organic chemistry
62	considerably higher than the manufacturer’s estimates. pERC agreed that the EGP’s re-analysis estimates were more reliable than those provided by the submitter and concluded that ofatumumab + chlorambucil is not co Add to Reading List Source URL: www.pcodr.ca Language: English - Date: 2014-12-04 16:10:34 Alkylating antineoplastic agents Nitrogen mustards Organochlorides Ofatumumab B-cell chronic lymphocytic leukemia Chlorambucil Fludarabine Leukemia Rituximab Chemistry Medicine Oncology
63	HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use TAXOTERE safely and effectively. See full prescribing information for TAXOTERE. TAXOTERE (docetaxel) Injection Conce Add to Reading List Source URL: www.accessdata.fda.gov Language: English - Date: 2014-11-17 17:44:37 Carbamates Alkaloids Benzoates Docetaxel Alkylating antineoplastic agents Stomach cancer Head and neck cancer Cisplatin Prostate cancer Chemistry Medicine Oncology
64	Vinorelbine Injection, USP R only WARNING Vinorelbine Injection, USP should be administered under the supervision of a physician experienced in the use of cancer chemotherapeutic agents. This product is for intravenous ( Add to Reading List Source URL: www.sagentpharma.com Language: English - Date: 2012-01-06 09:38:51 Eli Lilly and Company Ammine complexes Vinorelbine Extravasation Vinca alkaloid Lung cancer Cisplatin Metastatic breast cancer Lorazepam Chemistry Alkaloids Alkylating antineoplastic agents
65	• For patients with severe renal impairment (creatinine clearance <30 mL/min), the HIGHLIGHTS OF PRESCRIBING INFORMATION initial recommended dose is 65 mg/m2. (2.2) These highlights do not include all the information Add to Reading List Source URL: www.sagentpharma.com Language: English - Date: 2014-09-23 15:28:43 Oxaliplatin Fluorouracil Irinotecan Folinic acid Adjuvant therapy Esophageal cancer Carboplatin Cisplatin Extravasation Chemistry Alkylating antineoplastic agents Ammine complexes
66	HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use Topotecan Hydrochloride for Injection safely and efectively. See full prescribing information for Topotecan Hydrochl Add to Reading List Source URL: www.sagentpharma.com Language: English - Date: 2014-04-14 14:33:49 Ammine complexes Oncology Lactams Lactones Topotecan Carboplatin Cisplatin Chemotherapy Neutropenia Chemistry Medicine Alkylating antineoplastic agents
67	CATALOG OXALIPLATIN Added safety notifications on labels and cartons Add to Reading List Source URL: www.sagentpharma.com Language: English - Date: 2014-11-10 10:45:31 Organofluorides Oxaliplatin Chemotherapy regimens Prodrugs Fluorouracil Adjuvant therapy Esophageal cancer Irinotecan Folinic acid Chemistry Alkylating antineoplastic agents Ammine complexes
68	CATALOG CARBOPLATIN Easy-to-see features right on the package Labels are DistinctIV Add to Reading List Source URL: www.sagentpharma.com Language: English - Date: 2013-11-13 16:35:45 Carboplatin Cisplatin Ototoxicity Thrombocytopenia Gemcitabine Chemistry Alkylating antineoplastic agents Ammine complexes
69	Sagent Pharmaceuticals, Inc. Oxaliplatin Injection, USP / Oxaliplatin for Injection, USP Safety Data Sheet (SDS) Add to Reading List Source URL: www.sagentpharma.com Language: English - Date: 2014-11-10 10:45:32 Material safety data sheet SDS-PAGE Chemistry Alkylating antineoplastic agents Oxaliplatin
70	A Canadian Perspective on the Treatment of Unfit Patients with Chronic Lymphocytic Leukemia David MacDonald, MD, FRCP(C);* Silvy Lachance, MD, FRCP(C), CSPQ;† Loree Larratt, MD, FRCP(C)‡ Dr. David MacDonald, Assista Add to Reading List Source URL: www.newevidence.com Language: English* - Date: 2013-05-06 11:02:45 Alkylating antineoplastic agents Nitrogen mustards Organochlorides Lymphocytic leukemia B-cell chronic lymphocytic leukemia Fludarabine Leukemia Comorbidity Bendamustine Medicine Chemistry Oncology

UPDATE